(Press-News.org) Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older people experiencing memory impairment. Now a team headed by Prof. Gil Ast and Dr. Ron Bochner of Tel Aviv University's Department of Human Molecular Genetics have discovered that the same supplement improves the functioning of genes involved in degenerative brain disorders, including Parkinson's disease and Familial Dysautonomia (FD).
In FD, a rare genetic disorder that impacts the nervous system and appears almost exclusively in the Ashkenazi Jewish population, a genetic mutation prevents the brain from manufacturing healthy IKAP proteins – which likely have a hand in cell migration and aiding connections between nerves – leading to the early degeneration of neurons. When the supplement was applied to cells taken from FD patients, the gene function improved and an elevation in the level of IKAP protein was observed, reports Prof. Ast. These results were replicated in a second experiment which involved administering the supplement orally to mouse populations with FD.
The findings, which have been published in the journal Human Molecular Genetics, are very encouraging, says Prof. Ast. "That we see such an effect on the brain — the most important organ in relation to this disease — shows that the supplement can pass through the blood-brain barrier even when administered orally, and accumulate in sufficient amounts in the brain."
Slowing the death of nerve cells
Already approved for use as a supplement by the FDA, phosphatidylserine contains a molecule essential for transmitting signals between nerve cells in the brain. Prof. Ast and his fellow researchers decided to test whether the same chemical, which is naturally synthesized in the body and known to boost memory capability, could impact the genetic mutation which leads to FD.
Researchers applied a supplement derived from oysters, provided by the Israeli company Enzymotec, to cells collected from FD patients. Noticing a robust effect on the gene, including a jump in the production of healthy IKAP proteins, they then tested the same supplement on mouse models of FD, engineered with the same genetic mutation that causes the disease in humans.
The mice received the supplement orally, every two days for a period of three months. Researchers then conducted extensive genetic testing to assess the results of the treatment. "We found a significant increase of the protein in all the tissues of the body," reports Prof. Ast, including an eight-fold increase in the liver and 1.5-fold increase in the brain. "While the food supplement does not manufacture new nerve cells, it probably delays the death of existing ones," he adds.
Therapeutic potential for Parkinson's
That the supplement is able to improve conditions in the brain, even when given orally, is a significant finding, notes Prof. Ast. Most medications enter the body through the blood stream, but are incapable of breaking through the barrier between the blood and the brain.
In addition, the researchers say the supplement's positive effects extend beyond the production of IKAP. Not only did phosphatidylserine impact the gene associated with FD, but it also altered the level of a total of 2400 other genes — hundreds of which have been connected to Parkinson's disease in previous studies.
The researchers believe that the supplement may have a beneficial impact on a number of degenerative diseases of the brain, concludes Prof. Ast, including a major potential for the development of new medications which would help tens of millions of people worldwide suffering from these devastating diseases.
###
American Friends of Tel Aviv University supports Israel's leading, most comprehensive and most sought-after center of higher learning. Independently ranked 94th among the world's top universities for the impact of its research, TAU's innovations and discoveries are cited more often by the global scientific community than all but 10 other universities.
Internationally recognized for the scope and groundbreaking nature of its research and scholarship, Tel Aviv University consistently produces work with profound implications for the future.
Common food supplement fights degenerative brain disorders
Nutritional supplement delays advancement of Parkinson's and familial dysautonomia, Tel Aviv Researchers discover
2013-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Evaluating a new way to open clogged arteries
2013-05-21
CAMBRIDGE, MA -- Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including the risk of side effects.
A new study from MIT analyzes the potential usefulness of a new treatment that combines the benefits of angioplasty balloons and drug-releasing stents, but may pose fewer risks. With this new approach, a balloon is inflated in the artery for only a brief period, during which it releases a drug that prevents ...
Mayo Clinic: How gold nanoparticles can help fight ovarian cancer
2013-05-21
ROCHESTER, Minn. — Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective against ovarian cancer cells. The discovery is detailed in the current online issue of the Journal of Biological Chemistry.
"This study identifies a novel mechanism that protects ovarian cancer cells by preventing the cell death or apoptosis which should occur when they encounter positively charged nanoparticles," say the senior authors ...
Rice unveils method for tailoring optical processors
2013-05-21
HOUSTON -- (May 21, 2013) -- Rice University scientists have unveiled a robust new method for arranging metal nanoparticles in geometric patterns that can act as optical processors that transform incoming light signals into output of a different color. The breakthrough by a team of theoretical and applied physicists and engineers at Rice's Laboratory for Nanophotonics (LANP) is described this week in the Proceedings of the National Academy of Sciences.
Rice's team used the method to create an optical device in which incoming light could be directly controlled with light ...
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery
2013-05-21
LOUISVILLE, Ky. – Grapefruits have long been known for their health benefits, and the subtropical fruit may revolutionize how medical therapies like anti-cancer drugs are delivered to specific tumor cells.
University of Louisville researchers have uncovered how to create nanoparticles using natural lipids derived from grapefruit, and have discovered how to use them as drug delivery vehicles. UofL scientists Huang-Ge Zhang, D.V.M., Ph.D., Qilong Wang, Ph.D., and their team today (May 21, 2013), published their findings in Nature Communications.
"These nanoparticles, ...
The pirate ant: A new species from the Philippines with a bizarre pigmentation pattern
2013-05-21
Scientists discovered a new enigmatic species of ant coming from the Philippines. Cardiocondyla pirata or the pirate ant engages the imagination with a bizarre pigmentation pattern that has no equivalent worldwide. The female castes in the colonies of these species can be recognized by a distinctive dark stripe across the eyes that resembles a pirate eye patch, which inspired the authors to choose the name of the species. The study was published in the open access journal Zookeys.
"On a collection trip to the Philippines we looked for different species of the genus ...
Waiting for a sign? Researchers find potential brain 'switch' for new behavior
2013-05-21
ANN ARBOR—You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when your bag appears?
A new study from investigators at the University of Michigan and Eli Lilly may reveal the brain's "switch" for new behavior. They measured levels of a neurotransmitter called acetylcholine, which is involved in attention and memory, while rats monitored a screen for a signal. At the end of each trial, the rat had to indicate if a signal ...
JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children
2013-05-21
ARLINGTON, VA, May 21, 2013—The Journal of the Pediatric Infectious Diseases Society (JPIDS) today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis. It establishes standardized definitions, measurements, and other key attributes that will effect research. This is the first step as the group of international stakeholders collaborate to raise visibility and share evidence and resources that can improve children's access to prompt and effective treatment.
Consensus Statement on Research ...
Single-cell transfection tool enables added control for biological studies
2013-05-21
Northwestern University researchers have developed a new method for delivering molecules into single, targeted cells through temporary holes in the cell surface. The technique could find applications in drug delivery, cell therapy, and related biological fields.
Bulk electroporation — a technique used to deliver molecules into cells through reversible nanopores in the cell membrane that are caused by exposing them to electric pulses — is an increasingly popular method of cell transfection. (Cell transfection is the introduction of molecules, such as nucleic acids or proteins, ...
Tiny, implantable coil promises hope for emphysema patients
2013-05-21
ATS 2013, PHILADELPHIA ─ A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial effects of the device persist more than a year after initial treatment.
The study will be presented at the ATS 2013 International Conference.
"LVRC treatment results in significant and clinically relevant improvements in lung function, ability to exercise and quality of life for patients with emphysema," said ...
Exposure to traffic pollution increases asthma severity in pregnant women
2013-05-21
ATS 2013, PHILADELPHIA ─ Air pollutants from traffic are associated with increased asthma severity levels in pregnant asthmatic women, according to a new study.
"Air pollution is a known trigger for asthma symptoms," said lead author Janneane Gent, PhD, Research Scientist in Epidemiology (Environmental Health) at the Yale School of Public Health. "In our study, exposures were assessed using a sophisticated air pollution modeling system (Community Multiscale Air Quality, CMAQ) that permits community-level estimates (i.e., close to where the subject resides) instead ...
LAST 30 PRESS RELEASES:
Sea surface temperatures and deeper water temperatures reached a new record high in 2024
Connecting through culture: Understanding its relevance in intercultural lingua franca communication
Men more than three times as likely to die from a brain injury, new US study shows
Tongue cancer organoids reveal secrets of chemotherapy resistance
Applications, limitations, and prospects of different muscle atrophy models in sarcopenia and cachexia research
FIFAWC: A dataset with detailed annotation and rich semantics for group activity recognition
Transfer learning-enhanced physics-informed neural network (TLE-PINN): A breakthrough in melt pool prediction for laser melting
Holistic integrative medicine declaration
Hidden transport pathways in graphene confirmed, paving the way for next-generation device innovation
New Neurology® Open Access journal announced
Gaza: 64,000 deaths due to violence between October 2023 and June 2024, analysis suggests
Study by Sylvester, collaborators highlights global trends in risk factors linked to lung cancer deaths
Oil extraction might have triggered small earthquakes in Surrey
Launch of world’s most significant protein study set to usher in new understanding for medicine
New study from Chapman University reveals rapid return of water from ground to atmosphere through plants
World's darkest and clearest skies at risk from industrial megaproject
UC Irvine-led discovery of new skeletal tissue advances regenerative medicine potential
Pulse oximeters infrequently tested by manufacturers on diverse sets of subjects
Press Registration is open for the 2025 AAN Annual Meeting
New book connects eugenics to Big Tech
Electrifying your workout can boost muscles mass, strength, UTEP study finds
Renewed grant will continue UTIA’s integrated pest management program
Researchers find betrayal doesn’t necessarily make someone less trustworthy if we benefit
Pet dogs often overlooked as spreader of antimicrobial-resistant Salmonella
Pioneering new tool will spur advances in catalysis
Physical neglect as damaging to children’s social development as abuse
Earth scientist awarded National Medal of Science, highest honor US bestows on scientists
Research Spotlight: Lipid nanoparticle therapy developed to stop tumor growth and restore tumor suppression
Don’t write off logged tropical forests – converting to oil palm plantations has even wider effects on ecosystems
Chimpanzees are genetically adapted to local habitats and infections such as malaria
[Press-News.org] Common food supplement fights degenerative brain disordersNutritional supplement delays advancement of Parkinson's and familial dysautonomia, Tel Aviv Researchers discover